Preventive Effect on Stroke of a Calcium Antagonist and Its Mechanisms in SHR
Yasuo Nara, Motoki Tagami, Katsumi Ikeda, Masayuki Mano, Masahiro Kihara, Ryoichi Horie, Yukio Yamori
Abstract
Open-access reader
Yasuo Nara, Motoki Tagami, Katsumi Ikeda, Masayuki Mano, Masahiro Kihara, Ryoichi Horie, Yukio Yamori
Abstract
Open-access reader
In SHR, a Ca2+ antagonist, Diltiazem significantly reduced the incidence of stroke. Thymidine incorporation into cultured smooth muscle cells was suppressed by 10-4 M Diltiazem, so that strain difference disappeared. By autoradiogram Diltiazem was observed in cardiomyocyte organella and tended to concentrate finally on mitochondria.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
In SHR, a Ca2+ antagonist, Diltiazem significantly reduced the incidence of stroke. Thymidine incorporation into cultured smooth muscle cells was suppressed by 10-4 M Diltiazem, so that strain difference disappeared. By autoradiogram Diltiazem was observed in cardiomyocyte organella and tended to concentrate finally on mitochondria.
Key concepts: Diltiazem, Antagonist, Calcium, Stroke (engine), Mitochondrion, Internal medicine, Chemistry, Strain (injury)